A innovative immunoglobulin, designated 2H7, demonstrates remarkable cross-reactivity against simultaneous CD20 receptors found in both and patient species. This discovery offers promise for translational research into https://www.targetmol.com/compound/anti-monkey-human-cd20-antibody-2h7